We are a life sciences company committed to enabling healthier lives through the development of innovative products and services. We serve patients and physicians by providing early patient management information. We offer our services in the U.S. and globally through licensing and commercial partnerships. We conduct our business primarily as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Our laboratories are certified under the Clinical Laboratory Improvements Amendment of 1988, or CLIA, to perform high complexity laboratory testing and accredited by the College of American Pathologists, or CAP. Patient clinical samples are received by our laboratory locations where molecular diagnostic tests are performed and test reports are relayed to prescribing physicians. Our testing focus is principally in prenatal health that includes molecular based laboratory-developed tests, referred to as LDTs or tests, branded under the names MaterniT21® , HerediT®, MaterniT® GENOME, SensiGene®, NextView® and VisibiliT™.
Company profile
Ticker
SQNM
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
770365889
Latest filings (excl ownership)
15-12G
Securities registration termination
23 Sep 16
EFFECT
Notice of effectiveness
22 Sep 16
EFFECT
Notice of effectiveness
22 Sep 16
EFFECT
Notice of effectiveness
22 Sep 16
EFFECT
Notice of effectiveness
22 Sep 16
CT ORDER
Confidential treatment order
21 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
Latest ownership filings
SC 13G/A
Sequenom Inc
12 Jan 17
3
der Vaart Sandra D van
7 Sep 16
3
Benjamin R Miller
7 Sep 16
3
F SAMUEL EBERTS III
7 Sep 16
3
Initial statement of insider ownership
7 Sep 16
3
GLENN A EISENBERG
7 Sep 16
3
WILLIAM HAAS
7 Sep 16
4
GOLDMAN MYLA LAI
7 Sep 16
4
DEN BOOM DIRK VAN
7 Sep 16
4
CHARLES P SLACIK
7 Sep 16
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|